米国市場銘柄情報

RDHL レッドヒル・バイオファーマ

銘柄追加

0.450
-0.001-0.16%

終値 05/03 16:00 ET

0.458
+0.008+1.80%

市場後 17:46 ET

1,433.38万時価総額0.11直近PER

レッドヒル・バイオファーマに関するコメント

ログインコメントを投稿

Trytosaveabit

04/24 19:23

Update

$レッドヒル・バイオファーマ(RDHL.US)$ RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study Of RHB-107 (Upamostat), The Study Is Expected To Be Completed By The End Of 2024

Lax13

03/11 19:09

RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced on March 11, 2024, that the U.S. Patent and Trademark Office (USPTO) has issued a new patent for Talicia,

$レッドヒル・バイオファーマ(RDHL.US)$

Lax13

03/11 19:03

Finally, let’s double up!

$レッドヒル・バイオファーマ(RDHL.US)$

Lax13

03/06 22:58

Build that base and take off, I’m ready

$レッドヒル・バイオファーマ(RDHL.US)$

Stock Region

03/06 03:01

Medical Company Receives New Patent For COVID-19 Drug

RedHill Biopharma's New Patent: A Potential Game-Changer in the Fight Against Coronavirus.
In a significant development in the medical community, RedHill Biopharma Ltd ($RDHL) has been granted US patent number 11,918,560, titled "Serine Protease Inhibitor for Treating Coronavirus Infection". The implications of this breakthrough could be far-reaching, potentially reshaping our approach to managing and treating coronavirus infections. $レッドヒル・バイオファーマ(RDHL.US)$
...

JT99

03/05 20:39

News not power enough

$Redhill Biopharma (RDHL.US)$ Seem like the News does not have much effect on it.

Lax13

03/05 20:29

Good news, now run!

$レッドヒル・バイオファーマ(RDHL.US)$

Trytosaveabit

03/05 20:25

Update

$レッドヒル・バイオファーマ(RDHL.US)$ Redhill Biopharma And Apogee Biotechnology's Opaganib Selected By U.S. Government's Chemical Medical Countermeasures Program And Chemical Countermeasures Research Program For A Potential Medical Countermeasure Against Inhalation Sulfur Mustard Exposure

FattyChick

03/05 20:03

$レッドヒル・バイオファーマ(RDHL.US)$ RedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures Programs

Trytosaveabit

03/05 08:01

Hmm? We will see? Hehehe

$レッドヒル・バイオファーマ(RDHL.US)$ RedHill Biopharma Will Be Issued U.S. Patent Number 11,918,560 Tomorrow Titled "Serine Protease Inhibitor For Treating Coronavirus Infection"

まだコメントはありません

分析

アナリスト評価

データなし

目標株価

データなし

ホット

米国株

総合人気